ERIN NULF: Open Payments
NPI 1164692950 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,449 in 87 payments from 13 companies in 2025. Trend: 2023 $638 · 2024 $1,942 · 2025 $2,449
Food & beverage: $2,366Education: $83
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 24 | $658 |
| Janssen Biotech, Inc. | 23 | $638 |
| ABBVIE INC. | 18 | $595 |
| Lilly USA, LLC | 4 | $95 |
| LEO Pharma Inc. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| GENZYME CORPORATION | 1 | $72 |
| Galderma Laboratories, L.P. | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $41 |
Products named: TREMFYA, Bimzelx, SKYRIZI, RINVOQ, EBGLYSS, DUPIXENT, NEMLUVIO, Sotyktu.
Industry payments across WA — which companies pay providers there.
